It also validates that targets based on human genetics are more conducive to clinical translation, indicating the importance of WES, WGS and GWAS in drug discovery and development, as they point to pharmacologic inhibition of PCSK9 as a safe strategy to prevent or treat CAD. The gene discussed is PCSK9; the disease is coronary artery disorder.